Literature DB >> 31342740

Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?

Min Qiu1, Zachary Glass1, Qiaobing Xu1.   

Abstract

Genome-editing technologies hold tremendous potential for treating genetic diseases. However, the efficient and safe delivery of genome-editing elements to the location of interest, and the achievement of specific targeted gene correction without off-target side effect remains a big challenge. In this Perspective, we highlight recent developments and discuss the challenges of nonviral nanoparticles for the delivery of genome-editing tools. Finally, we will propose promising strategies to improve the delivery efficacy and advance the clinical translation of gene-editing technology.

Entities:  

Year:  2019        PMID： 31342740      PMCID： PMC7261392          DOI： 10.1021/acs.biomac.9b00783

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN： 1525-7797            Impact factor:   6.988


  67 in total

Review 1.  Non-viral delivery of genome-editing nucleases for gene therapy.

Authors:  M Wang; Z A Glass; Q Xu
Journal:  Gene Ther       Date:  2016-10-31       Impact factor: 5.250

Review 2.  Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA.

Authors:  Satoshi Uchida; Kazunori Kataoka
Journal:  J Biomed Mater Res A       Date:  2019-01-31       Impact factor: 4.396

3.  Intracellular Delivery of His-Tagged Genome-Editing Proteins Enabled by Nitrilotriacetic Acid-Containing Lipidoid Nanoparticles.

Authors:  Yamin Li; Alice Chukun Li; Qiaobing Xu
Journal:  Adv Healthc Mater       Date:  2018-11-22       Impact factor: 9.933

4.  Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells.

Authors:  Daesik Kim; Jungeun Kim; Junho K Hur; Kyung Wook Been; Sun-Heui Yoon; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2016-06-06       Impact factor: 54.908

5.  Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.

Authors:  Jin Chang; Xianghan Chen; Zachary Glass; Feng Gao; Lanqun Mao; Ming Wang; Qiaobing Xu
Journal:  Acc Chem Res       Date:  2018-12-26       Impact factor: 22.384

Review 6.  Non-Viral Delivery To Enable Genome Editing.

Authors:  Yuan Rui; David R Wilson; Jordan J Green
Journal:  Trends Biotechnol       Date:  2018-09-29       Impact factor: 19.536

7.  Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy.

Authors:  Ming Wang; Kyle Alberti; Shuo Sun; Carlos Luis Arellano; Qiaobing Xu
Journal:  Angew Chem Int Ed Engl       Date:  2014-02-12       Impact factor: 15.336

8.  Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy.

Authors:  Ming Wang; Shuo Sun; Caleb I Neufeld; Bernardo Perez-Ramirez; Qiaobing Xu
Journal:  Angew Chem Int Ed Engl       Date:  2014-10-06       Impact factor: 15.336

9.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.

Authors:  Prashant Mali; John Aach; P Benjamin Stranges; Kevin M Esvelt; Mark Moosburner; Sriram Kosuri; Luhan Yang; George M Church
Journal:  Nat Biotechnol       Date:  2013-08-01       Impact factor: 54.908

10.  Metal-organic frameworks for precise inclusion of single-stranded DNA and transfection in immune cells.

Authors:  Shuang Peng; Binglin Bie; Yangzesheng Sun; Min Liu; Hengjiang Cong; Wentao Zhou; Yucong Xia; Heng Tang; Hexiang Deng; Xiang Zhou
Journal:  Nat Commun       Date:  2018-04-03       Impact factor: 14.919
View more
  7 in total

1.  Calcium-based nanomaterials and their interrelation with chitosan: optimization for pCRISPR delivery.

Authors:  Navid Rabiee; Mojtaba Bagherzadeh; Amir Mohammad Ghadiri; Mahsa Kiani; Sepideh Ahmadi; Vahid Jajarmi; Yousef Fatahi; Abdullah Aldhaher; Mohammadreza Tahriri; Thomas J Webster; Ebrahim Mostafavi
Journal:  J Nanostructure Chem       Date:  2021-09-22

Review 2.  Inherent and Composite Hydrogels as Promising Materials to Limit Antimicrobial Resistance.

Authors:  Rahela Carpa; Alexei Remizovschi; Carla Andreea Culda; Anca Livia Butiuc-Keul
Journal:  Gels       Date:  2022-01-20

3.  CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation.

Authors:  Wujin Sun; Jinqiang Wang; Quanyin Hu; Xingwu Zhou; Ali Khademhosseini; Zhen Gu
Journal:  Sci Adv       Date:  2020-05-20       Impact factor: 14.136

Review 4.  The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing.

Authors:  Parichehr Hassanzadeh
Journal:  Life Sci       Date:  2021-03-04       Impact factor: 6.780

Review 5.  The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System.

Authors:  Huanhuan Qiao; Jieting Wu; Xiaodong Zhang; Jian Luo; Hao Wang; Dong Ming
Journal:  Front Chem       Date:  2021-12-16       Impact factor: 5.221

Review 6.  The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges.

Authors:  Fan Zhang; Yunxin Zhou; Junying Ding
Journal:  Cell Mol Biol Lett       Date:  2022-08-19       Impact factor: 8.702

Review 7.  Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles.

Authors:  Fen Wan; Mohamed S Draz; Mengjie Gu; Wei Yu; Zhi Ruan; Qixia Luo
Journal:  Pharmaceutics       Date:  2021-03-08       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.